Trailing-twelve-month (TTM) revenue is $2.24 Million with a year-over-year growth of (9.56%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $429,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q4 FY2025Period ended 2025-12-31 | $310,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-26 |
| Q1 FY2026Period ended 2026-03-31 | $494,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-12 |
| Q2 FY2026Period ended 2026-06-30 | $1,009,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-11 |
| TTM revenue | $2,242,000 |
Current P/S: $734,102,008 market capitalization ÷ $2,242,000 TTM revenue = 327.43x.
Market capitalization source: FMP quote. Quote observed 2026-10-05T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.01M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 10 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T12:50:35.383Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20252025-12-31 · USD |
|---|---|
| AUSTRALIA | $33,000 |
| GERMANY | $272,000 |
| UNITED STATES | $2M |
$2.24M
$2.24 Million
(9.56%)
vs. $2.48M a year ago (TTM)
(18.92%)
5 Year compound annual growth rate
1 Year
(9.56%)
3 Year
(15.76%)
5 Year
(18.92%)
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $1.91M | ($790,000) | (29.23%) |
| 2024 | $2.70M | ($31,821) | (1.16%) |
| 2023 | $2.73M | ($465,890) | (14.56%) |
| 2022 | $3.20M | ($2.63M) | (45.10%) |
| 2021 | $5.83M | +$372,722 | +6.83% |
TTM Growth
(9.56%)
3-Year CAGR
(15.76%)
5-Year CAGR
(18.92%)
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T12:50:35.383Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
